A new analysis finds that, despite advances in care, men and women with a diagnosis of heart failure continue to have worse survival rates than patients with certain common cancers.
The study included 56,658 adults in Scotland who were receiving care in a primary care setting, with a total of 147,938 person-years of follow-up. In men, heart failure was linked with worse survival than prostate cancer and bladder cancer, but better survival than lung cancer and colorectal cancer. In women, heart failure was linked with worse survival than breast cancer and colorectal cancer, but better survival than lung cancer and ovarian cancer.
“Our study shows that despite advances in the treatment of heart failure with newer drugs and devices, mortality rates for patients with heart failure remain significant and a major public health problem. Heart failure remains as malignant as many of the common cancers,” said Dr. Mamas Mamas, lead author of the European Journal of Heart Failure study.
Link to Study: http://onlinelibrary.wiley.com/doi/10.1002/ejhf.822
European Journal of Heart Failure is the international journal of the European Society of Cardiology dedicated to the advancement of knowledge in the field of heart failure. The Journal publishes reviews and editorials in order to improve the understanding, prevention, investigation and treatment of heart failure.